Evidence map›Paper›PMID 26264446›Full record

Trial reportInternational journal of cancer2016

Increased breast cancer screening and downstaging in Colombian women: A randomized trial of opportunistic breast-screening.

Raúl Murillo, Sandra Díaz, Fernando Perry, César Poveda, Marion Piñeros, Oswaldo Sánchez, Lina Buitrago, Oscar Gamboa, Teófilo Lozano, Hsiang Yu and 4 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. The Effect of Educational Intervention Based on the Theory of Planned Behavior on Mammography Screening in Iranian Women.Journal of cancer education : the official journal of the American Association for Cancer Education · 2020
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 4 countries.

Raúl MurilloInstituto Nacional De Cancerología De Colombia, Bogotá, Colombia.
Sandra DíazInstituto Nacional De Cancerología De Colombia, Bogotá, Colombia.
Fernando PerryInstituto Nacional De Cancerología De Colombia, Bogotá, Colombia.
César PovedaInstituto Nacional De Cancerología De Colombia, Bogotá, Colombia.
Marion PiñerosInstituto Nacional De Cancerología De Colombia, Bogotá, Colombia.
Oswaldo SánchezInstituto Nacional De Cancerología De Colombia, Bogotá, Colombia.
Lina BuitragoInstituto Nacional De Cancerología De Colombia, Bogotá, Colombia.
Oscar GamboaInstituto Nacional De Cancerología De Colombia, Bogotá, Colombia.
Teófilo LozanoInstituto Nacional De Cancerología De Colombia, Bogotá, Colombia.
Hsiang YuInstitute of Statistics, National Tsing-Hua University, Hsin-Chu, Taiwan.
Ching-Yun WangDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA.
Catherine DugganDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA.
David B ThomasDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA.
Benjamin O AndersonDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA.
Instituto Nacional de Cancerología · COFred Hutch Cancer Center · USNational Tsing Hua University · TW

Funding

World Health Organization 001
6 · The paper itself

Abstract

The lack of breast cancer screening in low and middle-income countries results in later stage diagnosis and worsened outcomes for women. A cluster randomized trial was performed in Bogotá, Colombia between 2008 and 2012 to evaluate effects of opportunistic breast cancer screening. Thirteen clinics were randomized to an intervention arm and 13 to a control arm. Physicians in intervention clinics were instructed to perform clinical breast examination on all women aged 50-69 years attending clinics for non-breast health issues, and then refer them for mammographic screening. Physicians in control clinics were not explicitly instructed to perform breast screening or mammography referrals, but could do so if they thought it indicated ("usual care"). Women were followed for 2-years postrandomization. 7,436 women were enrolled and 7,419 (99.8%) screened in intervention clinics, versus 8,419 enrolled and 1,108 (13.1%) screened in control clinics. Incidence ratios (IR) of early, advanced and all breast cancers were 2.9 (95% CI 1.1-9.2), 1.0 (0.3-3.5) and 1.9 (0.9-4.1) in the first (screening) year of the trial, and the cumulative IR for all breast cancers converged to 1.4 (0.7-2.8) by the end of follow-up (Year 2). Eighteen (69.2%) of 26 women with early stage disease had breast conservation surgery (BCS) versus 6 (42.5%) of 14 women with late-stage disease (p = 0.02). Fifteen (68.2%) of 22 women with breast cancer in the intervention group had BCS versus nine (50.0%) of 18 women in the control group (p = 0.34). Well-designed opportunistic clinic-based breast cancer screening programs may be useful for early breast cancer detection in LMICs.

Indexed as

Early Detection of CancerAgedBreast NeoplasmsFemaleGynecological ExaminationHumansMastectomy, SegmentalMiddle AgedNeoplasm StagingOutcome Assessment, Health Carebreast cancercluster randomized controlled triallow and middle income countriesopportunistic screening

Identifiers

PMID26264446
PMCPMC4832278
OpenAlexW1775926857

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.